Product NDC: | 0591-3775 |
Proprietary Name: | ATORVASTATIN CALCIUM |
Non Proprietary Name: | ATORVASTATIN CALCIUM |
Active Ingredient(s): | 20 mg/1 & nbsp; ATORVASTATIN CALCIUM |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0591-3775 |
Labeler Name: | Watson Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020702 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20111130 |
Package NDC: | 0591-3775-51 |
Package Description: | 5000 TABLET, FILM COATED in 1 BOTTLE (0591-3775-51) |
NDC Code | 0591-3775-51 |
Proprietary Name | ATORVASTATIN CALCIUM |
Package Description | 5000 TABLET, FILM COATED in 1 BOTTLE (0591-3775-51) |
Product NDC | 0591-3775 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ATORVASTATIN CALCIUM |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20111130 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Watson Laboratories, Inc. |
Substance Name | ATORVASTATIN CALCIUM |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |